Reid M Huber
CIK 1607052 · EVP, Chief Scientific Officer · last filed 2026-06-10
Reid M Huber is an EVP, Chief Scientific Officer who has filed 47 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for RAPP, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$9.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.69M
5
47
-$9.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | 20,400 | $38.40 | $783.4K | $499.4K | 3 | 2026-06-10 |
| CARGO Therapeutics, Inc. (CRGX) Delisted | Director | — | $4.47 | — | $0 | 4 | 2025-08-19 |
| TNGX | Director | 5,000 | $30.94 | $154.7K | $0 | 2 | 2023-06-08 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Director | 146,951 | $0.07 | $11.0K | $0 | 13 | 2023-01-20 |
| INCY | EVP, Chief Scientific Officer | 34,571 | $108.53 | $3.75M | -$9.61M | 25 | 2018-07-18 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2025-09-15 | RAPP | Buy (P) | +20,400 | $499.4K | EDGAR |
| 2025-08-19 | CARGO Therapeutics, Inc. (CRGX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-20 | CARGO Therapeutics, Inc. (CRGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | CARGO Therapeutics, Inc. (CRGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | CARGO Therapeutics, Inc. (CRGX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | TNGX | Grant (A) | +5,000 | $0 | EDGAR |
| 2023-01-20 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Exer (M) | +80,968 | $0 | EDGAR |
| 2023-01-05 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Exer (M) | +87,196 | $0 | EDGAR |